RES Group, an MIT spin-off in QSP modeling since 2001, is dedicated to accelerating and de-risking drug development. Utilizing mechanistic QSP modeling, we offer services including FIH dose projections for IND applications, toxicity projections, and support for early-stage drug development.
RES Group